Harvard Bioscience Net Profit Margin 2012-2026 | HBIO
Harvard Bioscience net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Harvard Bioscience Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $0.09B | $-0.01B | -10.47% |
| 2025-12-31 | $0.09B | $-0.06B | -64.37% |
| 2025-09-30 | $0.09B | $-0.05B | -60.23% |
| 2025-06-30 | $0.09B | $-0.06B | -64.04% |
| 2025-03-31 | $0.09B | $-0.06B | -63.04% |
| 2024-12-31 | $0.10B | $-0.01B | -13.68% |
| 2024-09-30 | $0.10B | $-0.02B | -15.31% |
| 2024-06-30 | $0.10B | $-0.01B | -10.89% |
| 2024-03-31 | $0.11B | $-0.01B | -8.41% |
| 2023-12-31 | $0.11B | $0.00B | -2.68% |
| 2023-09-30 | $0.11B | $0.00B | -2.68% |
| 2023-06-30 | $0.11B | $-0.01B | -4.39% |
| 2023-03-31 | $0.11B | $0.00B | -1.75% |
| 2022-12-31 | $0.11B | $-0.01B | -8.85% |
| 2022-09-30 | $0.12B | $-0.01B | -5.93% |
| 2022-06-30 | $0.12B | $0.00B | -3.31% |
| 2022-03-31 | $0.12B | $-0.01B | -4.96% |
| 2021-12-31 | $0.12B | 0 | 0.00% |
| 2021-09-30 | $0.12B | $0.00B | -1.71% |
| 2021-06-30 | $0.11B | $0.00B | -2.70% |
| 2021-03-31 | $0.11B | $-0.01B | -4.76% |
| 2020-12-31 | $0.10B | $-0.01B | -8.82% |
| 2020-09-30 | $0.10B | $-0.01B | -6.86% |
| 2020-06-30 | $0.11B | $-0.01B | -8.57% |
| 2020-03-31 | $0.11B | $-0.01B | -6.25% |
| 2019-12-31 | $0.12B | $0.00B | -3.45% |
| 2019-09-30 | $0.12B | $0.00B | -1.68% |
| 2019-06-30 | $0.12B | $0.00B | 0.83% |
| 2019-03-31 | $0.12B | 0 | 0.00% |
| 2018-12-31 | $0.12B | $0.00B | -1.64% |
| 2018-09-30 | $0.11B | $0.00B | -3.64% |
| 2018-06-30 | $0.10B | $0.00B | -4.00% |
| 2018-03-31 | $0.09B | $0.00B | -3.45% |
| 2017-12-31 | $0.08B | 0 | 0.00% |
| 2017-09-30 | $0.08B | $0.00B | -2.44% |
| 2017-06-30 | $0.09B | $0.00B | -4.55% |
| 2017-03-31 | $0.10B | $-0.01B | -5.26% |
| 2016-12-31 | $0.10B | $-0.01B | -4.81% |
| 2016-09-30 | $0.11B | $-0.02B | -19.81% |
| 2016-06-30 | $0.11B | $-0.02B | -18.69% |
| 2016-03-31 | $0.11B | $-0.02B | -17.27% |
| 2015-12-31 | $0.11B | $-0.02B | -17.43% |
| 2015-09-30 | $0.11B | $0.00B | -1.80% |
| 2015-06-30 | $0.11B | 0 | 0.00% |
| 2015-03-31 | $0.11B | $0.00B | 0.93% |
| 2014-12-31 | $0.11B | $0.00B | 2.78% |
| 2014-09-30 | $0.11B | $0.00B | 1.89% |
| 2014-06-30 | $0.11B | 0 | 0.00% |
| 2014-03-31 | $0.11B | $0.00B | -0.95% |
| 2013-12-31 | $0.11B | $0.00B | -1.90% |
| 2013-09-30 | $0.11B | 0 | 0.00% |
| 2013-06-30 | $0.11B | $0.00B | 0.94% |
| 2013-03-31 | $0.11B | $0.00B | 1.85% |
| 2012-12-31 | $0.11B | $0.00B | 2.73% |
| 2012-09-30 | $0.11B | $0.00B | 2.70% |
| 2012-06-30 | $0.11B | $0.00B | 2.70% |
| 2012-03-31 | $0.11B | $0.00B | 2.73% |
| 2011-12-31 | $0.11B | $0.00B | 3.70% |
| 2011-09-30 | $0.11B | $0.01B | 4.59% |
| 2011-06-30 | $0.11B | $0.02B | 16.51% |
| 2011-03-31 | $0.11B | $0.02B | 17.59% |
| 2010-12-31 | $0.11B | $0.02B | 17.59% |
| 2010-09-30 | $0.11B | $0.02B | 19.81% |
| 2010-06-30 | $0.10B | $0.01B | 8.91% |
| 2010-03-31 | $0.09B | $0.01B | 7.53% |
| 2009-12-31 | $0.09B | $0.01B | 8.14% |
| 2009-09-30 | $0.08B | $0.01B | 6.17% |
| 2009-06-30 | $0.08B | $0.01B | 6.25% |
| 2009-03-31 | $0.09B | $0.00B | 3.53% |
| 2008-12-31 | $0.09B | $0.00B | 2.27% |
| 2008-09-30 | $0.09B | $0.00B | -1.11% |
| 2008-06-30 | $0.09B | $0.00B | -1.12% |
| 2008-03-31 | $0.09B | $0.00B | -1.16% |
| 2007-12-31 | $0.08B | $0.00B | -2.41% |
| 2007-09-30 | $0.08B | $0.00B | -3.75% |
| 2007-06-30 | $0.08B | $0.00B | -5.00% |
| 2007-03-31 | $0.08B | $0.00B | -2.56% |
| 2006-12-31 | $0.08B | $0.00B | -1.32% |
| 2006-09-30 | $0.07B | $-0.01B | -11.11% |
| 2006-06-30 | $0.07B | $-0.01B | -10.00% |
| 2006-03-31 | $0.07B | $-0.03B | -45.59% |
| 2005-12-31 | $0.07B | $-0.03B | -47.76% |
| 2005-09-30 | $0.05B | $-0.02B | -41.51% |
| 2005-06-30 | $0.05B | $-0.02B | -41.51% |
| 2005-03-31 | $0.06B | $0.00B | 3.39% |
| 2004-12-31 | $0.07B | $0.00B | 3.08% |
| 2004-09-30 | $0.09B | $0.00B | 3.53% |
| 2004-06-30 | $0.09B | $0.00B | 3.37% |
| 2004-03-31 | $0.09B | $0.00B | 4.49% |
| 2003-12-31 | $0.09B | $0.01B | 5.81% |
| 2003-09-30 | $0.08B | $0.00B | 2.47% |
| 2003-06-30 | $0.07B | $0.00B | 1.37% |
| 2003-03-31 | $0.07B | $0.00B | 1.54% |
| 2002-12-31 | $0.06B | $0.00B | 1.72% |
| 2002-09-30 | $0.05B | $0.00B | 3.92% |
| 2002-06-30 | $0.05B | $0.00B | 4.08% |
| 2002-03-31 | $0.05B | $0.00B | -8.89% |
| 2001-12-31 | $0.04B | $-0.01B | -11.90% |
| 2001-09-30 | $0.04B | $0.03B | 74.36% |
| 2001-06-30 | $0.04B | $0.01B | 33.33% |
| 2001-03-31 | $0.03B | $-0.05B | -136.36% |
| 2000-12-31 | $0.03B | $-0.05B | -158.06% |
| 2000-09-30 | $0.03B | $-0.08B | -273.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |